Amylin Pharmaceuticals Inc. (AMLN: Quote) announced after the close Friday that it agreed to be acquired by Bristol-Myers Squibb (BMY: Quote) for $31.00 per share in cash.
Amylin Pharmaceuticals gapped open sharply higher Monday, but traded in a narrow range throughout the session. Shares finished up by 2.51 at $30.71 on the highest volume of the year and set a new high for the year.
Click here to receive FREE breaking news email alerts for Amylin Pharmaceuticals Inc and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com